Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

NanoBio reorganizes under BlueWillow name; raises $10mm in Series A round

Executive Summary

BlueWillow Biologics (formerly NanoBio; intranasal vaccines) closed a $10mm Series A round co-led by North Coast Technology Investors, Line Moon Ventures, and the University of Michigan's MINTS tech transfer arm.
Deal Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
      • Topical Delivery
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register